Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic

Genome editing using clustered regularly interspersed short palindromic repeats (CRISPR) and CRISPR-associated proteins offers the potential to facilitate safe and effective treatment of genetic diseases refractory to other types of intervention. Here, we identify some of the major challenges for cl...

Full description

Bibliographic Details
Main Authors: Nicol, D, Eckstein, L, Morrison, M, Sherkow, J, Otlowski, M, Whitton, T, Bubela, T, Burdon, K, Chalmers, D, Chan, S, Charlesworth, J, Critchley, C, Crossley, M, de Lacey, S, Dickinson, J, Hewitt, A, Kamens, J, Kato, K, Kleiderman, E, Kodama, S, Liddicoat, J, Mackey, D, Newson, A, Nielsen, J, Wagner, J, McWhirter, R
Format: Journal article
Language:English
Published: BioMed Central 2017
_version_ 1797085392786161664
author Nicol, D
Eckstein, L
Morrison, M
Sherkow, J
Otlowski, M
Whitton, T
Bubela, T
Burdon, K
Chalmers, D
Chan, S
Charlesworth, J
Critchley, C
Crossley, M
de Lacey, S
Dickinson, J
Hewitt, A
Kamens, J
Kato, K
Kleiderman, E
Kodama, S
Liddicoat, J
Mackey, D
Newson, A
Nielsen, J
Wagner, J
McWhirter, R
author_facet Nicol, D
Eckstein, L
Morrison, M
Sherkow, J
Otlowski, M
Whitton, T
Bubela, T
Burdon, K
Chalmers, D
Chan, S
Charlesworth, J
Critchley, C
Crossley, M
de Lacey, S
Dickinson, J
Hewitt, A
Kamens, J
Kato, K
Kleiderman, E
Kodama, S
Liddicoat, J
Mackey, D
Newson, A
Nielsen, J
Wagner, J
McWhirter, R
author_sort Nicol, D
collection OXFORD
description Genome editing using clustered regularly interspersed short palindromic repeats (CRISPR) and CRISPR-associated proteins offers the potential to facilitate safe and effective treatment of genetic diseases refractory to other types of intervention. Here, we identify some of the major challenges for clinicians, regulators, and human research ethics committees in the clinical translation of CRISPR-mediated somatic cell therapy.
first_indexed 2024-03-07T02:08:21Z
format Journal article
id oxford-uuid:9fc20fe2-3c18-4260-87ac-d1656af2850a
institution University of Oxford
language English
last_indexed 2024-03-07T02:08:21Z
publishDate 2017
publisher BioMed Central
record_format dspace
spelling oxford-uuid:9fc20fe2-3c18-4260-87ac-d1656af2850a2022-03-27T02:00:19ZKey challenges in bringing CRISPR-mediated somatic cell therapy into the clinicJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9fc20fe2-3c18-4260-87ac-d1656af2850aEnglishSymplectic Elements at OxfordBioMed Central2017Nicol, DEckstein, LMorrison, MSherkow, JOtlowski, MWhitton, TBubela, TBurdon, KChalmers, DChan, SCharlesworth, JCritchley, CCrossley, Mde Lacey, SDickinson, JHewitt, AKamens, JKato, KKleiderman, EKodama, SLiddicoat, JMackey, DNewson, ANielsen, JWagner, JMcWhirter, RGenome editing using clustered regularly interspersed short palindromic repeats (CRISPR) and CRISPR-associated proteins offers the potential to facilitate safe and effective treatment of genetic diseases refractory to other types of intervention. Here, we identify some of the major challenges for clinicians, regulators, and human research ethics committees in the clinical translation of CRISPR-mediated somatic cell therapy.
spellingShingle Nicol, D
Eckstein, L
Morrison, M
Sherkow, J
Otlowski, M
Whitton, T
Bubela, T
Burdon, K
Chalmers, D
Chan, S
Charlesworth, J
Critchley, C
Crossley, M
de Lacey, S
Dickinson, J
Hewitt, A
Kamens, J
Kato, K
Kleiderman, E
Kodama, S
Liddicoat, J
Mackey, D
Newson, A
Nielsen, J
Wagner, J
McWhirter, R
Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
title Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
title_full Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
title_fullStr Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
title_full_unstemmed Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
title_short Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic
title_sort key challenges in bringing crispr mediated somatic cell therapy into the clinic
work_keys_str_mv AT nicold keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT ecksteinl keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT morrisonm keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT sherkowj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT otlowskim keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT whittont keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT bubelat keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT burdonk keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT chalmersd keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT chans keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT charlesworthj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT critchleyc keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT crossleym keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT delaceys keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT dickinsonj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT hewitta keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT kamensj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT katok keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT kleidermane keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT kodamas keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT liddicoatj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT mackeyd keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT newsona keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT nielsenj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT wagnerj keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic
AT mcwhirterr keychallengesinbringingcrisprmediatedsomaticcelltherapyintotheclinic